United States Department of Veterans Affairs
United States Department of Veterans Affairs
National HIV/AIDS Program
Patients' Home > Treatment > Drug Dosing Toolkit > VireadEnlarge Text Size:Small Font SizeMedium Font SizeLarge Font Size

Drug Dosing Toolkit

Viread (tenofovir)

Type of Drug: Nucleotide Reverse Transcriptase Inhibitor

Nucleotide reverse transcriptase inhibitors are also known as NRTIs, nucleotide analogues, or "nukes."

When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.

Approved adult dosing

one 300 mg tablet, once a day

  • Daily

    Viread 300

    Viread

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Persons with kidney problems may need an adjustment to their dosing schedule, or may need a different drug

Side effects

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Kidney impairment
  • Viread is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Disclaimer:

This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.